Comparative Effectiveness of Standard Care With IV Thrombolysis Versus Without IV Thrombolysis for Mild Ischemic Stroke
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Choi, Jay Chol | - |
dc.contributor.author | Jang, Min Uk | - |
dc.contributor.author | Kang, Kyusik | - |
dc.contributor.author | Park, Jong-Moo | - |
dc.contributor.author | Ko, Youngchai | - |
dc.contributor.author | Lee, Soo-Joo | - |
dc.contributor.author | Cha, Jae-Kwan | - |
dc.contributor.author | Kim, Dae-Hyun | - |
dc.contributor.author | Park, Sang Soon | - |
dc.contributor.author | Park, Tai Hwan | - |
dc.contributor.author | Lee, Kyung Bok | - |
dc.contributor.author | Lee, Jun | - |
dc.contributor.author | Kim, Joon-Tae | - |
dc.contributor.author | Cho, Ki-Hyun | - |
dc.contributor.author | Yu, Kyung-Ho | - |
dc.contributor.author | Oh, Mi-Sun | - |
dc.contributor.author | Lee, Byung-Chul | - |
dc.contributor.author | Cho, Yong-Jin | - |
dc.contributor.author | Kim, Dong-Eog | - |
dc.contributor.author | Lee, Ji Sung | - |
dc.contributor.author | Lee, Juneyoung | - |
dc.contributor.author | Gorelick, Philip B. | - |
dc.contributor.author | Bae, Hee-Joon | - |
dc.date.accessioned | 2021-08-11T20:46:53Z | - |
dc.date.available | 2021-08-11T20:46:53Z | - |
dc.date.issued | 2015-01 | - |
dc.identifier.issn | 2047-9980 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/11021 | - |
dc.description.abstract | Background-One third of patients presenting with initially mild strokes have unfavorable outcomes, and the efficacy of intravenous thrombolysis (IVT) in this population has not been proven. This study aimed to evaluate the comparative effectiveness of standard care with IVT versus without IVT in mild stroke patients. Methods and Results-Using a multicenter stroke registry database, we identified patients with acute ischemic stroke who presented within 4.5 hours of symptom onset and had initial National Institutes of Health Stroke Scale scores <= 5. Multivariable logistic analysis and propensity score matching were used to adjust for baseline imbalances between the patients who did and did not receive IVT. Adjusted odds ratios and 95% CIs of IVT were estimated for 3-month modified Rankin Scale scores of 0 to 1 and symptomatic. Of 13 117 patients with stroke who were hospitalized between April 2008 and May 2012, 1386 met the eligibility criteria, and 194 (14.0%) were treated with IVT. For a modified Rankin Scale of 0 to 1 at 3 months, the adjusted odds ratios were 1.96 (95% CI, 1.28 to 3.00; P=0.002) by multivariable logistic analysis and 1.68 (1.10 to 2.56; P=0.02) by propensity score matching analysis, respectively. There was a statistically nonsignificant excess of symptomatic hemorrhagic transformation (odds ratios=3.76 [0.95 to 16.42; P=0.06] and 4.81 [0.84 to 49.34; P=0.09]), respectively. Conclusions-In this observational registry-based study, standard care with IVT is more effective than not receiving IVT in mild ischemic stroke patients, and there is a statistically nonsignificant risk of symptomatic hemorrhagic transformation. | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Wiley-Blackwell | - |
dc.title | Comparative Effectiveness of Standard Care With IV Thrombolysis Versus Without IV Thrombolysis for Mild Ischemic Stroke | - |
dc.type | Article | - |
dc.publisher.location | 미국 | - |
dc.identifier.doi | 10.1161/JAHA.114.001306 | - |
dc.identifier.scopusid | 2-s2.0-85016503837 | - |
dc.identifier.wosid | 000348597500036 | - |
dc.identifier.bibliographicCitation | Journal of the American Heart Association, v.4, no.1 | - |
dc.citation.title | Journal of the American Heart Association | - |
dc.citation.volume | 4 | - |
dc.citation.number | 1 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Cardiovascular System & Cardiology | - |
dc.relation.journalWebOfScienceCategory | Cardiac & Cardiovascular Systems | - |
dc.subject.keywordPlus | TISSUE-PLASMINOGEN ACTIVATOR | - |
dc.subject.keywordPlus | CLINICAL-TRIAL | - |
dc.subject.keywordPlus | INTRAVENOUS THROMBOLYSIS | - |
dc.subject.keywordPlus | INTRACRANIAL HEMORRHAGE | - |
dc.subject.keywordPlus | EARLY MANAGEMENT | - |
dc.subject.keywordPlus | 0.6 MG/KG | - |
dc.subject.keywordPlus | J-ACT | - |
dc.subject.keywordPlus | SYMPTOMS | - |
dc.subject.keywordPlus | ALTEPLASE | - |
dc.subject.keywordPlus | OUTCOMES | - |
dc.subject.keywordAuthor | ischemic stroke | - |
dc.subject.keywordAuthor | outcome | - |
dc.subject.keywordAuthor | thrombolysis | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.